New symposium highlighting innovative uses of catalysis in pharmaceutical applications - April 28, 2016
Catalysis is an increasingly important tool for creating complex molecules across all sectors, from academic R&D to commercial production - whether the objective is to reduce costs, increase efficiency or to explore new synthetic possibilities.
Apeiron Synthesis Inc. has launched the Catalysis in Chemistry Symposium to provide a forum for chemists to discuss new breakthroughs and powerful new applications in the field. Please join us in Cambridge, one of the World's great centers of scientific creativity and accomplishment, to learn from the leading innovators in the theory and practice of Catalysis in Chemistry.
Seb Caille (Amgen), David Conlon (Bristol-Myers Squibb), Chris Senanayake (Boehringer Ingelheim), Eric Jacobsen (Harvard), Jim Morken (Boston College), Greg Verdine(Harvard), Jin-Quan Yu (Scripps Research Institute), Krzysztof Skowerski (Apeiron Synthesis)